Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 11 studies | 29% ± 10% | |
endothelial cell | 7 studies | 23% ± 10% | |
epithelial cell | 6 studies | 23% ± 7% | |
GABAergic neuron | 6 studies | 35% ± 16% | |
glutamatergic neuron | 5 studies | 42% ± 16% | |
interneuron | 5 studies | 32% ± 18% | |
ciliated cell | 5 studies | 22% ± 5% | |
astrocyte | 5 studies | 31% ± 9% | |
oligodendrocyte precursor cell | 5 studies | 28% ± 9% | |
neuron | 3 studies | 29% ± 11% | |
fibroblast | 3 studies | 17% ± 1% | |
transit amplifying cell | 3 studies | 30% ± 11% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 8 studies | 34% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 1006.81 | 21 / 21 | 100% | 63.31 | 504 / 504 |
esophagus | 100% | 903.20 | 1445 / 1445 | 100% | 43.99 | 183 / 183 |
ovary | 100% | 1141.92 | 180 / 180 | 100% | 58.21 | 430 / 430 |
skin | 100% | 1080.44 | 1809 / 1809 | 100% | 47.52 | 472 / 472 |
stomach | 100% | 638.70 | 359 / 359 | 100% | 68.28 | 286 / 286 |
uterus | 100% | 1153.84 | 170 / 170 | 100% | 56.53 | 459 / 459 |
brain | 100% | 991.12 | 2639 / 2642 | 100% | 45.65 | 705 / 705 |
intestine | 100% | 957.53 | 966 / 966 | 100% | 63.32 | 526 / 527 |
prostate | 100% | 880.36 | 245 / 245 | 100% | 39.62 | 501 / 502 |
lung | 100% | 805.90 | 577 / 578 | 100% | 45.47 | 1154 / 1155 |
kidney | 100% | 812.94 | 89 / 89 | 100% | 29.76 | 897 / 901 |
thymus | 100% | 913.68 | 653 / 653 | 100% | 38.15 | 602 / 605 |
breast | 100% | 837.97 | 459 / 459 | 99% | 46.07 | 1111 / 1118 |
adrenal gland | 100% | 1079.87 | 258 / 258 | 99% | 37.77 | 228 / 230 |
liver | 100% | 483.52 | 225 / 226 | 99% | 30.95 | 403 / 406 |
pancreas | 99% | 485.16 | 324 / 328 | 99% | 35.04 | 177 / 178 |
adipose | 100% | 822.61 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 38.19 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 30.76 | 29 / 29 |
spleen | 100% | 726.99 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 50.87 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 47.51 | 1 / 1 |
blood vessel | 100% | 763.63 | 1332 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 690.41 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 713.20 | 851 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 75% | 515.25 | 699 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016255 | Biological process | attachment of GPI anchor to protein |
GO_0046425 | Biological process | regulation of receptor signaling pathway via JAK-STAT |
GO_0006506 | Biological process | GPI anchor biosynthetic process |
GO_0042765 | Cellular component | GPI-anchor transamidase complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0034235 | Molecular function | GPI anchor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PIGU |
Protein name | Phosphatidylinositol glycan anchor biosynthesis class U Phosphatidylinositol glycan anchor biosynthesis class U protein (Cell division cycle protein 91-like 1) (Protein CDC91-like 1) (GPI transamidase component PIG-U) |
Synonyms | CDC91L1 UNQ3055/PRO9875 PSEC0205 |
Description | FUNCTION: Component of the GPI transamidase complex, necessary for transfer of GPI to proteins . May be involved in the recognition of either the GPI attachment signal or the lipid portion of GPI. . |
Accessions | Q9H490 Q5JWU1 ENST00000438215.1 ENST00000374820.6 [Q9H490-2] ENST00000217446.8 [Q9H490-1] |